SOCIETY FOR MATERNAL-FETAL MEDICINE

Lobbying for SOCIETY FOR MATERNAL-FETAL MEDICINE

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 expenses · posted Oct 23, 2025

Lobbying activity 2

Health Issues

inclusion of pregnant and lactating women in clinical trials, federal support for maternal mortality review committees and perinatal quality collaboratives

Budget/Appropriations

FY 2025 and FY 2026 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research & Quality, and the Health Resources and Services Administration

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.